{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:09:45Z","timestamp":1774472985161,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evaluate the usefulness of repeated cardiac magnetic resonance imaging (CMR) and fluorodeoxyglucose positron emission tomography (FDG PET\/CT) for CS diagnosis in patients with an initial \u201cpossible\u201d CS diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a retrospective cohort study in 35 patients diagnosed with possible CS by our multidisciplinary team (MDT), who received repeated CMR and FDG PET\/CT within 12\u00a0months after diagnosis. Imaging modalities were scored on abnormalities suggestive for CS and classified as CMR+\/PET+, CMR+\/PET\u2212, CMR\u2212\/PET+ and CMR\u2212\/PET\u2212. Primary endpoint was final MDT diagnosis of CS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After re-evaluation, nine patients (25.7%) were reclassified as probable CS and 16 patients (45.7%) as unlikely CS. Two patients started immunosuppressive treatment after re-evaluation. At baseline, eleven patients (31.4%) showed late gadolinium enhancement (LGE) on CMR (CMR+) and 26 (74.3%) patients showed myocardial FDG-uptake (PET+). At re-evaluation, nine patients (25.7%) showed LGE (CMR+), while 16 patients (45.7%) showed myocardial FDG-uptake (PET+). When considering both imaging modalities together, 82.6% of patients with CMR\u2212\/PET+ at baseline were reclassified as possible or unlikely CS, while 36.4% of patients with CMR+ at baseline were reclassified as probable CS. Three patients with initial CMR\u2212\/PET+ showed LGE at re-evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Repeated CMR and FDG PET\/CT may be useful in establishing or rejecting CS diagnosis, when initial diagnosis is uncertain. However, clinical relevance has to be further determined.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13550-021-00870-y","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T12:02:48Z","timestamp":1640001768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The usefulness of repeated CMR and FDG PET\/CT in the diagnosis of patients with initial possible cardiac sarcoidosis"],"prefix":"10.1186","volume":"11","author":[{"given":"H.","family":"Mathijssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. W. H.","family":"Tjoeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G. M.","family":"Keijsers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L. M.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Akdim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. W.","family":"van Es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. T.","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. V.","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"issue":"6","key":"870_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204\u201311.","journal-title":"Circulation"},{"issue":"12","key":"870_CR2","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","volume":"10","author":"V Kouranos","year":"2017","unstructured":"Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10(12):1437\u201347.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"870_CR3","first-page":"167","volume":"119","author":"A Perry","year":"1995","unstructured":"Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119(2):167\u201372.","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"870_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Hear Rhythm. 2014;11(7):1304\u201323.","journal-title":"Hear Rhythm"},{"issue":"3","key":"870_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/pace.12277","volume":"37","author":"PB Nery","year":"2014","unstructured":"Nery PB, Mc Ardle BA, Redpath CJ, Leung E, Lemery R, Dekemp R, et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2014;37(3):364\u201374.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"6","key":"870_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00428-010-1003-8","volume":"458","author":"IN Bagwan","year":"2011","unstructured":"Bagwan IN, Hooper LVB, Sheppard MN. Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies. Virchows Arch. 2011;458(6):671\u20138.","journal-title":"Virchows Arch"},{"issue":"11","key":"870_CR7","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis-digest version. Circ J. 2019;83(11):2329\u201388.","journal-title":"Circ J"},{"issue":"5","key":"870_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","volume":"6","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389\u2013402.","journal-title":"Lancet Respir Med"},{"key":"870_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02359-y","author":"M Okune","year":"2020","unstructured":"Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T, et al. Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis. J Nucl Cardiol. 2020. https:\/\/doi.org\/10.1007\/s12350-020-02359-y.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"870_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12350-012-9653-3","volume":"20","author":"M Soussan","year":"2013","unstructured":"Soussan M, Brillet P-Y, Nunes H, Pop G, Ouvrier M-J, Naggara N, et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20(1):120\u20137.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"870_CR11","doi-asserted-by":"publisher","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","volume":"11","author":"T Vita","year":"2018","unstructured":"Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, et al. Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11(1):e007030.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"870_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","volume":"19","author":"EC Wicks","year":"2018","unstructured":"Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, et al. Diagnostic accuracy and prognostic value of simultaneous hybrid 18 F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2018;19(7):757\u201367.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"870_CR13","first-page":"89","volume":"27","author":"H Hiraga","year":"2007","unstructured":"Hiraga H, Yuwai K, Hiroe M. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord. 2007;27:89\u2013102.","journal-title":"Jpn J Sarcoidosis Granulomatous Disord"},{"issue":"2","key":"870_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","volume":"43","author":"H Ohira","year":"2016","unstructured":"Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, et al. Comparison of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2016;43(2):259\u201369.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"870_CR15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","volume":"189","author":"ED Crouser","year":"2014","unstructured":"Crouser ED, Ono C, Tran T, He X, Raman SV. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med. 2014;189(1):109\u201312.","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"870_CR16","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","volume":"26","author":"S Ishimaru","year":"2005","unstructured":"Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26(15):1538\u201343.","journal-title":"Eur Heart J"},{"issue":"1","key":"870_CR17","doi-asserted-by":"publisher","first-page":"81.e9","DOI":"10.1016\/j.crad.2018.09.015","volume":"74","author":"B Sgard","year":"2019","unstructured":"Sgard B, Brillet P-Y, Bouvry D, Djelbani S, Nunes H, Meune C, et al. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis. Clin Radiol. 2019;74(1):81.e9-81.e18.","journal-title":"Clin Radiol"},{"issue":"4","key":"870_CR18","doi-asserted-by":"publisher","first-page":"e190140","DOI":"10.1148\/ryct.2020190140","volume":"2","author":"RA Coulden","year":"2020","unstructured":"Coulden RA, Sonnex EP, Abele JT, Crean AM. Utility of FDG PET and cardiac MRI in diagnosis and monitoring of immunosuppressive treatment in cardiac sarcoidosis. Radiol Cardiothorac Imaging. 2020;2(4):e190140.","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"1","key":"870_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","volume":"21","author":"MT Osborne","year":"2014","unstructured":"Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21(1):166\u201374.","journal-title":"J Nucl Cardiol"},{"key":"870_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.06.016","author":"NA Gilotra","year":"2021","unstructured":"Gilotra NA, Griffin JM, Pavlovic N, Houston BA, Chasler J, Goetz C, et al. Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review. J Card Fail. 2021. https:\/\/doi.org\/10.1016\/j.cardfail.2021.06.016.","journal-title":"J Card Fail"},{"issue":"11","key":"870_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.12968\/hmed.2016.77.11.614","volume":"77","author":"V Kouranos","year":"2016","unstructured":"Kouranos V, Sharma R, Wells AU. Accurate diagnosis of cardiac sarcoidosis needs a multidisciplinary approach. Br J Hosp Med. 2016;77(11):614\u20135.","journal-title":"Br J Hosp Med"},{"issue":"7","key":"870_CR22","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1097\/RLU.0000000000001063","volume":"41","author":"R Tang","year":"2016","unstructured":"Tang R, Wang JT-Y, Wang L, Le K, Huang Y, Hickey AJ, et al. Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis. Clin Nucl Med. 2016;41(7):e327\u201339.","journal-title":"Clin Nucl Med"},{"key":"870_CR23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/1754-9485.13121","volume":"65","author":"SS Sankaran","year":"2020","unstructured":"Sankaran SS, Kyprianou K, Cherk MH, Nadebaum DP, Beech PA, Khor R, et al. Excellent suppression of physiological myocardial FDG activity in patients with cardiac sarcoidosis. J Med Imaging Radiat Oncol. 2020;65:54\u20139.","journal-title":"J Med Imaging Radiat Oncol"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-021-00870-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-021-00870-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-021-00870-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T08:00:02Z","timestamp":1674115202000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-021-00870-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1186\/s13550-021-00870-y","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"26 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Local institutional review board approval was obtained with a waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}